Hepatitis B trials in China

In China 104 Also abroad 192

104 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
Where
Hong Kong
People
1,500
Run by
Humanity and Health Research Centre
See details and how to joinNCT02863757
No phaseTaking people
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
Where
Beijing, Shanghai
Age
18 years to 80 years
People
72
Run by
Huashan Hospital
See details and how to joinNCT06923280
Phase 2Taking people
A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Where
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Kunming, Shenzhen, Wuhan, Zunyi
Age
18 years to 65 years
People
200
Run by
Ausper Biopharma Co., Ltd.
See details and how to joinNCT07069569
Phase 1Taking people
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
Where
Chengdu, Chongqing, Hangzhou, Shanghai, Zhengzhou
Age
18 years to 65 years
People
32
Run by
Ausper Biopharma Co., Ltd.
See details and how to joinNCT07600788
Phase 2Taking people
A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Jiangmen, Kunming, Liuzhou, Meizhou, Nanchang, Nanjing, Qingyuan, Shanghai, Shenyang, Shenzhen, Wuhan, Xiamen, Xi’an, Yichang
Age
18 years to 65 years
People
320
Run by
Ausper Biopharma Co., Ltd.
See details and how to joinNCT07635186
Phase 3Taking people
Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
Where
Guangzhou
Age
18 years and over
People
540
Run by
Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07606950
Phase 1Taking people
A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
Where
Ch’ang-ch’un, Hangzhou
Age
18 years to 65 years
People
110
Run by
Ausper Biopharma Co., Ltd.
See details and how to joinNCT07511218
Phase 2Taking people
Study of AHB-171 in Chronic Hepatitis B Participants
Where
Beijing, Changzhou, Chengdu, Chongqing, Guangzhou, Hangzhou, Jilin City, Nanning, Xiamen, Zhengzhou
Age
18 years to 65 years
People
138
Run by
Ausper Biopharma Co., Ltd.
See details and how to joinNCT07630727
Phase 2Taking people
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
Where
Beijing
Age
35 years to 65 years
People
80
Run by
Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT07709520
No phaseNot yet taking people in China
A Study on the Consistency Evaluation of Digital PCR Technology for Quantitative Detection of HBV Nucleic Acid
Where
Beijing
Age
18 years and over
People
200
Run by
Beijing Municipal Administration of Hospitals
See details and how to joinNCT07684209
Phase 1Taking people
A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
Where
Chengdu
Age
18 years to 65 years
People
9
Run by
Jiyan Liu
See details and how to joinNCT07051187
Phase 4Enrolling by invitation
TAF in Early/Middle Pregnancy With CHB
Where
Guangzhou
Age
20 years to 40 years
People
816
Run by
The Third Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07668934
Phase 2Taking people
Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
Where
Chongqing
Age
18 years to 45 years
People
45
Run by
Huahui Health
See details and how to joinNCT07519330
Early phase 1Not yet taking people in China
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Where
Hangzhou, Ningbo
Age
18 years to 65 years
People
156
Run by
Ningbo No.2 Hospital
See details and how to joinNCT07553767
Phase 1Taking people
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
Where
Changsha
Age
18 years to 60 years
People
20
Run by
Sclnow Biotechnology Co., Ltd.
See details and how to joinNCT03826433
No phaseNot yet taking people in China
A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha
Where
Shanghai
Age
18 years to 65 years
People
10,000
Run by
xieqing
See details and how to joinNCT07537387
No phaseTaking people
The Role and Regulatory Mechanism of Germinal Center Immune Response in Hepatitis B Virus Infection
Where
Guangzhou
Age
18 years to 75 years
People
280
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07240350
No phaseNot yet taking people in China
Union-FAST: An Intelligent-Agent Intervention to Increase Antiviral Treatment Uptake in Diagnosed-but-Untreated Hepatitis B Patients
Where
Wuhan
Age
18 years and over
People
2,000
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07520123
No phaseTaking people
Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
Where
Guangzhou, Zhuhai
People
16,300
Run by
Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06966908
No phaseTaking people
MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
Where
Shenyang
Age
18 years to 80 years
People
600
Run by
Shengjing Hospital
See details and how to joinNCT06779058
Phase 3Not yet taking people in China
A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
Where
Shanghai
Age
18 years to 65 years
People
1,208
Run by
Beijing Continent Pharmaceutical Co, Ltd.
See details and how to joinNCT07412236
Phase 1/2Taking people
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
Where
Wuhan
Age
18 years to 75 years
People
76
Run by
Beijing Tuohua Weiye Biotechnology Co., Ltd.
See details and how to joinNCT07413549
Phase 3Taking people
To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
Where
Hangzhou
Age
18 years to 70 years
People
526
Run by
Fujian Akeylink Biotechnology Co., Ltd.
See details and how to joinNCT07090759
Early phase 1Taking people
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
Where
Beijing
Age
18 years to 60 years
People
132
Run by
Peking University People's Hospital
See details and how to joinNCT07328711
Phase 3Taking people
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
Where
Zhengzhou
Age
18 years to 65 years
People
120
Run by
Zhigang Ren
See details and how to joinNCT07307586